PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.
about
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@en
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@nl
type
label
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@en
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@nl
prefLabel
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@en
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@nl
P2093
P2860
P50
P1433
P1476
PGC-1alpha levels correlate wi ...... o metabolism-targeted therapy.
@en
P2093
Aránzazu García-Grande
José Miguel García
Lourdes Gutiérrez
Paloma Martín-Acosta
Sara Laine-Menéndez
Virginia Calvo
P2860
P2888
P356
10.1038/S41598-017-17009-6
P407
P577
2017-11-30T00:00:00Z
P6179
1093000014